Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 57.91 USD 6.9% Market Closed
Market Cap: 4.9B USD

Intrinsic Value

The intrinsic value of one VRNA stock under the Base Case scenario is 40.49 USD. Compared to the current market price of 57.91 USD, Verona Pharma PLC is Overvalued by 30%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VRNA Intrinsic Value
40.49 USD
Overvaluation 30%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Verona Pharma PLC

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
VRNA
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for VRNA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Verona Pharma PLC
NASDAQ:VRNA
UK
Pharmaceuticals
Market Cap
4.9B USD
IPO
Mar 30, 2005
UK
Pharmaceuticals
Market Cap
4.9B USD
IPO
Mar 30, 2005
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about VRNA?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Verona Pharma PLC
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Verona Pharma PLC

Current Assets 453.6m
Cash & Short-Term Investments 399.8m
Receivables 37.3m
Other Current Assets 16.6m
Non-Current Assets 20.7m
Long-Term Investments 15m
PP&E 3.2m
Intangibles 545k
Other Non-Current Assets 2m
Efficiency

Free Cash Flow Analysis
Verona Pharma PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Verona Pharma PLC

Revenue
42.3m USD
Cost of Revenue
-2.6m USD
Gross Profit
39.7m USD
Operating Expenses
-194.3m USD
Operating Income
-154.6m USD
Other Expenses
-18.8m USD
Net Income
-173.4m USD
Fundamental Scores

VRNA Profitability Score
Profitability Due Diligence

Verona Pharma PLC's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Positive Gross Profit
Positive 3-Years Revenue Growth
Declining ROE
20/100
Profitability
Score

Verona Pharma PLC's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

VRNA Solvency Score
Solvency Due Diligence

Verona Pharma PLC's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Low D/E
65/100
Solvency
Score

Verona Pharma PLC's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VRNA Price Targets Summary
Verona Pharma PLC

Wall Street analysts forecast VRNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VRNA is 81.94 USD with a low forecast of 72.72 USD and a high forecast of 97.65 USD.

Lowest
Price Target
72.72 USD
26% Upside
Average
Price Target
81.94 USD
41% Upside
Highest
Price Target
97.65 USD
69% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Verona Pharma PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for VRNA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

VRNA Insider Trading
Buy and sell transactions by insiders

VRNA News

What is the Intrinsic Value of one VRNA stock?

The intrinsic value of one VRNA stock under the Base Case scenario is 40.49 USD.

Is VRNA stock undervalued or overvalued?

Compared to the current market price of 57.91 USD, Verona Pharma PLC is Overvalued by 30%.

Back to Top